CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. RESEARCH METHODOLOGY

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. TOP PLAYER POSITIONING
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rising prevalence of eye related diseases worldwide
3.5.1.2. Rapid technological advancements in ophthalmology
3.5.1.3. Increasing focus on customer training and education along with awareness
3.5.1.4. High adoption of digital devices worldwide

3.5.2. Restraints

3.5.2.1. Low awareness about eye related diseases
3.5.2.2. Dearth of skilled professionals

3.5.3. Opportunities

3.5.3.1. Emerging nations - A great opportunity for ophthalmic devices manufacturers
3.5.3.2. Programs and initiatives worldwide to reduce the burden of eye related diseases

3.6. GOVERNMENT REGULATIONS

3.6.1. FDA
3.6.2. CE Mark
3.6.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

CHAPTER 4 GLOBAL OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SURGICAL DEVICES

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Refractive error surgical devices

4.2.4.1. Market size and forecast
4.2.4.2. Excimers and femtosecond lasers

4.2.4.2.1. Market size and forecast

4.2.4.3. Microkeratomes

4.2.4.3.1. Market size and forecast

4.2.5. Glaucoma surgical devices

4.2.5.1. Market size and forecast
4.2.5.2. Implants and stents

4.2.5.2.1. Market size and forecast

4.2.5.3. Glaucoma drainage devices

4.2.5.3.1. Market size and forecast

4.2.5.4. Glaucoma laser devices

4.2.5.4.1. Market size and forecast

4.2.6. Cataract surgical devices

4.2.6.1. Market size and forecast
4.2.6.2. Intraocular lenses

4.2.6.2.1. Market size and forecast

4.2.6.3. Viscoelastics

4.2.6.3.1. Market size and forecast

4.2.6.4. Phacoemulsification systems

4.2.6.4.1. Market size and forecast

4.2.7. Vitreoretinal surgical devices

4.2.7.1. Market size and forecast
4.2.7.2. Vitrectomy machines and vitrectomy packs

4.2.7.2.1. Market size and forecast

4.2.7.3. Photocoagulation lasers

4.2.7.3.1. Market size and forecast

4.2.7.4. Illumination devices

4.2.7.4.1. Market size and forecast

4.3. DIAGNOSTIC DEVICES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities

4.3.2.1. Market size and forecast

4.3.3. Refractors

4.3.3.1. Market size and forecast

4.3.4. Corneal topography systems

4.3.4.1. Market size and forecast

4.3.5. Retinal ultrasound systems

4.3.5.1. Market size and forecast

4.3.6. Fundus camera

4.3.6.1. Market size and forecast

4.3.7. Ophthalmoscopes

4.3.7.1. Market size and forecast

4.3.8. Optical coherence tomography systems

4.3.8.1. Market size and forecast

4.3.9. Perimeters

4.3.9.1. Market size and forecast

4.3.10. Slit lamps

4.3.10.1. Market size and forecast

4.3.11. Tonometers

4.3.11.1. Market size and forecast

4.4. VISION CARE DEVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Contact lenses

4.4.4.1. Market size and forecast

4.4.5. Spectacle lenses

4.4.5.1. Market size and forecast

CHAPTER 5 GLOBAL OPHTHALMIC DEVICES MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Italy market size and forecast
5.3.8. Spain market size and forecast
5.3.9. Rest of the Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. Australia market size and forecast
5.4.7. India market size and forecast
5.4.8. South Korea market size and forecast
5.4.9. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil market size and forecast
5.5.5. Saudi Arabia market size and forecast
5.5.6. South Africa market size and forecast
5.5.7. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. ALCON, INC.

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. CARL ZEISS MEDITEC AG

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves & developments

6.3. ESSILOR INTERNATIONAL S.A.

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance

6.4. HAAG-STREIT HOLDING AG

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance

6.5. HOYA CORPORATION

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. JOHNSON & JOHNSON

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. NIDEK CO., LTD.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments

6.8. TOPCON CORPORATION

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments

6.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments

6.10. ZIEMER OPHTHALMIC SYSTEMS AG

6.10.1. Company overview
6.10.2. Business performance
6.10.3. Key strategic moves & developments